New Blood Test Simplifies PCOS Diagnosis, Improves Patient Experience

PCOS Diagnosis: Understanding the Rotterdam Criteria and New AMH Testing Millions of women worldwide suffer from Polycystic Ovary Syndrome (PCOS), a hormonal disorder with various symptoms. Early diagnosis is crucial for managing health risks. Traditionally, PCOS diagnosis relied on the Rotterdam criteria, requiring two out of three symptoms: irregular periods, hyperandrogens, and polycystic ovaries on ultrasound. However, this can be invasive and uncomfortable for many women. "This video explains the Rotterdam criteria, outlining the three key symptoms," explains Dr. Jennale, a physician specializing in women's health. "Two out of three are needed for a diagnosis." Recently, Anti-Mullerian Hormone (AMH) blood tests have emerged as a less invasive alternative. Dr. Jennale highlights the benefits of this newer approach, emphasizing its convenience and speed. This method is particularly beneficial because many women find traditional ultrasound exams uncomfortable, especially vaginal ultrasounds. PCOS is linked to serious health issues, including cardiovascular disease, metabolic syndrome, and insulin resistance. Early detection allows for timely intervention, improving long-term health outcomes. The video also notes that higher body fat correlates with more severe symptoms. "The higher the body fat, the worse the symptoms," says Dr. Jennale. "When you lose body fat, the symptoms lessen." The video concludes by briefly discussing common treatments such as Metformin, contraceptives, and Spironolactone, emphasizing the importance of consulting a doctor for personalized care.